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The devices and systems are medical fluid treatment thera-
pies. The device and systems are configured and capable of 
operating based on small volumes of fluids. The devices and 
systems include a pump configured for small volume of a 
fluid. The pump may include a first conduit configured for 
inflow of the fluid; a second conduit configured for outflow of 
the fluid; a fluid chamber configured to move the fluid through 
the pump; a diaphragm configured to force the fluid through 
the fluid chamber by indirectly exerting force on the fluid 
chamber; and a connector configured to removably attach the 
pump to a motor. 
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DEVICES AND SYSTEMS FOR MEDICAL 
FLUID TREATMENT 
CROSS-REFERENCE TO RELATED 
APPLICATIONS 
This application claims priority to U.S. Provisional Appli-
cation No. 61/376,720 filed Aug. 25, 2010, which is hereby 
incorporated by reference. 
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FIELD 
This disclosure relates to devices and systems for medical 
fluid treatment therapies. More particularly, the disclosure 
relates to devices and systems for extracorporeal blood treat-
ment having accurate fluid management of small volumes. 
BACKGROUND 
Medical fluid treatment therapies are generally used to 
treat loss of renal function or renal failure. A person's renal 
system can fail due to disease, injury or other causes, such as 
complications associated with extracorporeal membrane 
oxygenation (ECMO) treatment. During renal failure or loss 
of renal function, toxic end products of metabolism (e.g., 
urea, creatinine, uric acid, and others) can accumulate in 
blood and tissues because the balance of water, minerals and 
the excretion of daily metabolic load can be reduced or no 
longer possible. 
2 
include a first conduit configured for inflow of the fluid; a 
second conduit configured for outflow of the fluid; a fluid 
chamber configured to move the fluid through the pump; a 
diaphragm configured to force the fluid through the fluid 
chamber by indirectly exerting force on the fluid chamber; 
and a connector configured to removably attach the pump to 
a motor. 
According to some embodiments, the fluid pump may 
include a piston connected to the diaphragm, the piston con-
lO figured to linearly move a surface, the diaphragm. 
The fluid pump may include a housing, the housing includ-
ing at least a first section and a second section. The first 
section may include a cavity filled with an incompressible 
15 fluid, the first conduit, the second conduit and the fluid cham-
ber, and the cavity is disposed between the fluid chamber and 
the diaphragm. According to other embodiments, the dia-
phragm may be fixedly attached to the housing between the 
first section and the second section. The diaphragm may also 
20 be configured to move between a first position and a second 
position; the first position corresponding to when a surface of 
the diaphragm protrudes into the first section and the second 
position corresponding to when the surface of the diaphragm 
protrudes into the second section. According to some embodi-
25 ments, the diaphragm may be configured to transfer force to 
the incompressible fluid when the diaphragm is in the second 
position, and the incompressible fluid is configured to move 
the fluid through the fluid chamber. 
According to some embodiments, the second section may 
30 include a piston. According to some embodiments, the first 
section may have an extending surface and the second section 
has an extending surface, the extending surface of the first 
section facing the extending surface of the second section. 
According to further embodiments, the pump may include a 
35 cap, the cap including ports configured to connect tubing to 
the first and second conduits. 
Renal support can be provided by a continuous renal 
replacement therapy (CRRT), such as continuous veno-
venous hemofiltration (CVVH) or continuous venovenous 40 
hemodiafiltration (CVVHDF). These therapies are designed 
According to some embodiments, the disclosure may 
relate to a medical fluid therapy system. The system may 
include at least one medical fluid pump, the pump including: 
a fluid chamber configured to move a fluid through the pump; 
a diaphragm configured to force the fluid through the fluid 
chamber by indirectly exerting force on the fluid chamber; a 
plurality of valves, the valves including at least a first valve 
and a second valve configured to control the flow of fluid 
through the fluid pump; a motor; and a controller configured 
to collectively control the movement of the motor and valves 
with respect to each other. 
to remove metabolic waste and excess fluid from patient in 
fluid overload and those who need renal support. These thera-
pies allow provide continuous fluid, electrolyte and toxin 
clearance even in the absence of adequate native renal func- 45 
ti on via convective or dialytic processes through a permeable 
membrane. 
CRRT is a common renal replacement therapy for critically According some embodiments, the system may include: a 
fluid balance system; the fluid balance system including a first 
pump and a second pump, each pump including the fluid 
chamber, the rolling diaphragm and the first valve and the 
second valve; wherein the first pump and second pump are 
offset of each other. 
According to some embodiments, the system may further 
ill and hemodynamically unstable patients in the pediatric 
intensive care unit. However, there is currently no FDA 50 
approved CRRT device for use in the neonatal and pediatric 
populations. Generally, physicians resort to utilizing devices 
approved for adults to treat children. The adult approved 
CRRT devices are not designed forthe smaller volumes inher-
ent in treating children. 55 include a display; the display includes a user interface con-
figured to enter operating parameters to control the system. 
The user interface may display the operating status of the 
system. The operating status may include flow rates of the 
SUMMARY 
Thus, there is a need for devices capable of handling a 
smaller fluid volume, such as in the pediatric patient. The 60 
disclosure relates to devices and systems for medical fluid 
treatment. These devices and systems are configured for 
small fluid volume and allow operating parameters for a small 
fluid volume. 
fluid flowing through the pump and the angle of the valve. 
According to some embodiments, the system may include 
at least one pump receiving member, the at least one pump 
receiving member having an depression configured to receive 
a portion of the pump, wherein the pump includes a housing, 
the housing including at least a first section and a second 
According to some embodiments, the disclosure may 
relate to a fluid pump for medical fluid treatment therapies 
configured for small volumes of a fluid. The pump may 
65 section, wherein the first section has an extending surface and 
the second section has an extending surface, the extending 
surface of the first section facing the extending surface of the 
US 8,821,135 B2 
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second section, and wherein the depression is configured to 
receive the extending surface of at least the second section. 
According to some embodiments, the system may include 
at least first and second self-contained sections, wherein the 
first section includes the controller; and the second section 
includes the pump receiving member. The system may also be 
configured for a plurality of fluid treatment modes. The con-
troller may be configured to control the motor and valves 
based on entered volume parameters or selected treatment 
modes. According to some embodiments, an operating status 
of the system may be stored at predetermined intervals. 
4 
FIG. 12 is an example of a valve dwelve screen of the user 
interface according to some embodiments; 
FIG. 13 is an example of a locked screen of the user inter-
face according to some embodiments; 
FIG. 14 is an example of a normal run screen of the user 
interface according to some embodiments; 
FIG. 15 is an example of a heater screen of the user inter-
face according to some embodiments; 
FIG. 16 is an example of an error screen of the user inter-
lO face according to some embodiments. 
According to some embodiments, the system may be con-
figured to be connected to another medical fluid treatment 
therapy device. In some embodiments, the controller may 
control the system based on the other medical fluid treatment 15 
therapy or extracorporeal treatment systems and devices. The 
other medical fluid treatment device may include at least one 
FIGS. 17 and 18 are examples of the modular system 
according to some embodiments. 
DESCRIPTION OF EMBODIMENTS 
The following description, numerous specific details are 
set forth such as examples of specific components, devices, 
methods, etc., in order to provide a thorough understanding of 
embodiments of the disclosure. It will be apparent, however, 
to one skilled in the art that these specific details need not be 
employed to practice embodiments of the disclosure. In other 
of an ECMO device, cardiopulmonary bypass device, ven-
tricular assist device, plasma exchange device, apheresis 
device, or hemoperfusion device. According to some embodi- 20 
ments, the controller may control the system based on a 
selected mode, connected therapy device, adjunct therapy, 
patient type, or any combination thereof. The controller may 
control at least one operating parameter based on the selected 
mode, connected therapy device, adjunct therapy, patient 25 
type, or any combination thereof. 
instances, well-known materials or methods have not been 
described in detail in order to avoid unnecessarily obscuring 
embodiments of the disclosure. While the disclosure is sus-
ceptible to various modifications and alternative forms, spe-
According to other embodiments, the disclosure may relate 
to a disposable kit for a medical therapy system. The dispos-
able kit may include a first conduit configured for inflow of 
the fluid; a second conduit configured for outflow of the fluid; 30 
a fluid chamber configured to move the fluid through the 
pump; a diaphragm configured to force the fluid through the 
fluid chamber by indirectly exerting force on the fluid cham-
ber; and a connector configured to removably attach the pump 
cific embodiments thereof are shown by way of example in 
the drawings and will herein be described in detail. It should 
be understood, however, that there is no intent to limit the 
disclosure to the particular forms disclosed, but on the con-
trary, the disclosure is to cover all modifications, equivalents, 
and alternatives falling within the spirit and scope of the 
disclosure. 
The disclosure relates to devices and systems for medical 
to a motor. 
In some embodiments, the kit may include tubing config-
ured for the medical therapy system. 
DESCRIPTION OF FIGURES 
The disclosure can be better understood with the reference 
to the following drawings and description. The components in 
the figures are not necessarily to scale, emphasis being placed 
upon illustrating the principles of the disclosure. 
FIG. 1 is a schematic diagram of a medical fluid treatment 
system according to some embodiments; 
FIG. 2 is a schematic representation of the fluid systems of 
a medical fluid treatment system according to some embodi-
ments; 
35 fluid treatment therapies, such as extracorporeal treatment 
therapies, to assist patients with severe organ deficiencies. 
The extracorporeal treatments may include but are not limited 
to CRRT, CVVH, CVVHD, and CVVHDF. It will be under-
stood that components (such as the blood pump) of the 
40 devices and systems, as well as the devices and systems in 
their entirety, may be implemented into and/or with other 
medical fluid treatment therapy or extracorporeal treatment 
systems and devices. According to embodiments, the system 
may automatically adjust the operation in accordance with 
45 the other medical fluid treatment therapy or extracorporeal 
treatment systems and devices. These other devices may 
include but are not limited to an ECMO device, cardiopulmo-
nary bypass device, ventricular assist device, plasma 
exchange device, apheresis device, or hemoperfusion device. 
FIG. 3 is a sectional view ofafluid pump according to some 50 
embodiments; 
According to embodiments, the disclosure may relate to 
medical fluid treatment devices and systems capable of small 
volume fluid management. In some embodiments, the medi-
cal fluid treatment devices and systems may provide to CRRT 
therapy. In some embodiments, the medical fluid treatment 
FIG. 4 is an enlarged view of a fluid pump within the 
system according to some embodiments; 
FIG. 5 is a view of a medical fluid treatment system accord-
ing to some embodiments; 
FIG. 6 is a view of a medical fluid treatment system accord-
ing to other embodiments; 
FIG. 7 is a schematic representation of a controller of the 
system according to some embodiments; 
FIG. 8 is a main screen view of the user interface according 
to some embodiments; 
FIG. 9 is a graphing screen view of the user interface 
according to some embodiments; 
FIG. 10 is an alarm screen view of the user interface 
according to some embodiments; 
FIG. 11 is an example of a manual screen of the user 
interface according to some embodiments; 
55 devices and systems may be capable of CVVH therapy. In 
other embodiments, the medical fluid treatment devices and 
systems may be capable of CVVHDF therapy. In other 
embodiments, the medical fluid treatment devices and sys-
tems may be capable of CVVHD therapy. In further embodi-
60 ments, medical fluid treatment devices and systems may be 
capable of providing all CVVH therapy, CVVHD therapy, 
and CVVHDF therapy. 
Systems and Devices 
In some embodiments, the systems and devices may 
65 include a modular fluid therapy system. FIG. 1 shows an 
example of a schematic of a system 100 according to some 
embodiments. 
US 8,821,135 B2 
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In some embodiments, the system 100 may include a medi-
cal fluid therapy system 110. The system 110 may include a 
plurality of sensors and/or detectors 112. In some embodi-
ments, the sensors 112 may include but are not limited to fluid 
sensors, temperature sensors, and operation sensors and 
detectors. The systems may also include additional sensors 
not shown or described below. 
According some embodiments, the fluid sensors config-
ured to detect or measure the fluid characteristics of a fluid 
along the flow paths. The fluid characteristics include but are 
not limited to pressure of a fluid flowing through a path, the 
flow characteristics of the fluid flowing through a path, such 
as flow rate, the volume of the fluid passing through a path, or 
combination thereof. The fluid sensors may include but are 
not limited to a flow meter, a pressure sensor, a volume sensor, 
or a combination thereof. It will be understood that the fluid 
sensors described with respect to the systems may be of the 
same or different type. The sensors may be of any known 
sensors. The fluid sensors may be disposed within the system 
6 
motor provided for the pump configuration 114. In other 
embodiments, the system 110 may include a separate control-
ler for each motor provided for the pump configuration 114. 
According to some embodiments, the controller may be a 
CPU. The CPU may be any known may be one or more of any 
known central processing unit, including but not limited to a 
processor, or a microprocessor. The CPU may be coupled 
directly or indirectly to memory elements. The memory 118 
may include random access memory (RAM), read only 
10 memory (ROM), disk drive, tape drive, etc., or a combina-
tions thereof. The memory may also include a frame buffer 
for storing image data arrays. The operating status detected 
by the sensors and/or detectors 112 may be stored in the 
memory 118. The processes of the system (described below) 
15 maybe implemented as a routine that is stored in the memory 
118. 
According to some embodiments, the system 100 may 
to detect or measure the fluid characteristics of the blood 20 
flowing through the system including but are not limited to 
the blood entering the system and exiting the patient, the 
blood entering the hemofilter, and the blood exiting the sys-
tem and entering the patient. The fluid sensors may also be 
disposed within the system to detect or measure the fluid 25 
characteristics of the ultrafiltrate, replacement fluid, or dialy-
sate flowing through the system including but are not limited 
further include display system 120. In some embodiments, 
the display system 120 may be integrated with the medical 
fluid therapy system 110. In other embodiments, the display 
system 120 may be separately connectable to the medical 
fluid therapy system 110. FIGS. 17and18 show examples of 
a system having an integrated modular configuration and/or a 
separate display unit. 
In some embodiments, the display system 120 may include 
an input device 122 and a display device 124. In some 
embodiments, the input device 122 may include but is not 
limited to a touch screen interface, a keyboard, a mouse and 
trackball. The display device may be any known display 
device. 
to the ultrafiltrate or used dialysate exiting the hemofilter 
and/or collected, the replacement fluid exiting the system and 
entering the patient, and the dialysate entering the hemofilter 30 
In further embodiments, the sensors 112 may further 
include at least sensor and/or detector configured to deter-
mine/detect the temperature of the fluid flowing through the 
system. The sensor and/or detector may be any known tem-
perature sensor. The sensor and/or detector may be in com- 35 
bination with a heater. 
In further embodiments, the display device 120 may 
optionally include a controller 126 and a memory 128. 
According to some embodiments where the display system 
120 may be integrated with the medical fluid therapy system 
110, the display system 120 and the medical fluid therapy 
system 110 may share at least one controller and memory. In 
According to some embodiments, the sensors 112 may 
include at least one sensor and/or detectors that may be used 
to determine the operation status of the system. The sensors 
and/or detectors may provide feedback of the systems and 
devices according to the embodiments. The sensor and/or 
detector may be any known detector. The detectors may be 
configured to detect the presence of certain fluids, for 
example, the presence of blood, ultrafiltrate, or air. 
In some embodiments, the system 110 may include at least 
one pump configuration 114. According to some embodi-
ments, the pump configuration may include at least one pump 
and a corresponding valve. The valves may be configured to 
control the fluid direction through the systems. In some 
embodiments, the valves may be controlled electronically. In 
other embodiments, the valves may be controlled mechani-
cally. The valves may include but are not limited to pinch 
valves. The pinch valves may be made of a sterile, biocom-
patible material such as polished acrylic. The valves are fur-
ther described below with respect to the figures. In further 
embodiments, the pump configurations 114 may include a 
plurality of fluid pumps along the paths. The fluid pumps may 
be configured or structured to pump a small volume of fluid. 
The pumps may be controlled collectively with the valves to 
move the fluid by a controller. In some embodiments, the 
pump configurations 114 may include a motor to actuate the 
pump. 
further embodiments, the display system 120 may include a 
separate controller and memory. 
According to some embodiments, the controller 126 may 
40 be a CPU. The CPU may be any known may be one or more 
of any known central processing unit, including but not lim-
ited to a processor, or a microprocessor. The CPU may be 
coupled directly or indirectly to memory elements. The 
memory 128 may include random access memory (RAM), 
45 read only memory (ROM), disk drive, tape drive, etc., or a 
combinations thereof. The memory may also include a frame 
buffer for storing image data arrays. The operating status 
detected by the sensors and/or detectors 112 may be stored in 
the memory 128. The processes of the system (described 
50 below) maybe implemented as a routine that is stored in the 
memory 128. 
According to further embodiments, at least one of the 
medical fluid therapy system 110 and the display system 120 
may be connected to a network 130. According to some 
55 embodiments, the integrated system of the medical fluid 
therapy system 110 and the display system 120 may be con-
nected to a network. In further embodiments, one or both of 
the medical fluid therapy system 110 and the display system 
120 may be connected to a network. The network connection 
60 may be a hard wired or wireless connection to a network, for 
example, a local area network, or the Internet. According to 
some embodiments, the network may be a hospital network 
so the operation notes of the system 100 may be stored in the The system 110 may further include at least one controller 
116 configured to control the sensors 112 and pump configu-
ration 114. According to some embodiments, the system 110 65 
may include a plurality of controllers. The system 110 may 
include a main controller and a separate controller for each 
electronic medical record for the patient. 
In some embodiments, all components or some of the 
components of the system 100 may be further connected 
directly (via wired connections) to another medical treatment 
US 8,821,135 B2 
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therapy device, including, but not limited to, ECMO. In fur-
ther embodiments, the readings may be transmitted via wire-
less network connection to other devices. 
These components and operation of the system are 
described further below with respect to the figures. 
Fluid Pump Housing 
FIG. 3 shows a sectional view of a fluid pump 300 accord-
ing to some embodiments. According to some embodiments, 
the fluid pump 300 may include a housing 310. In some 
embodiments, the housing 310 may include at least one sec-
tion. In some embodiments, the fluid pump 300 may include 
a first section 320 and a second section 350. 
The first section 320 (may also be referred to as a fluid or 
blood compartment) may include a fluid chamber 322. The 
fluid chamber 322 may be a membrane configured to hold the 
fluid entering the pump. The chamber may be made of a 
flexible material, such as Gum Rubber. The chamber 322 may 
include at least two conduits: a first conduit (or inlet conduit) 
for fluid entering the pump and a second conduit (or outlet 
conduit) for fluid exiting the pump. 
In some embodiments, the chamber 322 may be fixedly 
attached to and/or confined within the housing 310. The 
chamber 322 may include an upper surface 321 and a lower 
surface 323. The upper surface 321 of the chamber 322 may 
8 
flexed. The diaphragm 340 may be a rolling diaphragm. The 
diaphragm 340 may have a flange design with a moldable 
a-ring that can be positioned between the first and second 
section. This configuration maintains proper orientation of a 
mechanical actuator 360 when attached to the diaphragm 340. 
The diaphragm 340 may include a surface 342 that may be 
configured to flex or move upon exertion of force by the 
mechanical actuator 360. In some embodiments, in resting 
(first) position, the diaphragm 340 has an ascending convo-
10 lution into the section. The surface 342 extends in the second 
section substantially parallel to the cap 330. 
In some embodiments, the diaphragm 340 may be config-
ured to move from the resting position based on the move-
ment of the mechanical actuator. The diaphragm 340 may be 
15 configured to move to second and third positions. In the 
second position, when the mechanical actuator 360 is moved 
away from the chamber 322, the surface 342 of the diaphragm 
340 may be positioned further away from the cap 330 in the 
second section 350. In the third position, when the mechani-
20 cal actuator 360 is moved toward the chamber 322, the surface 
342 of the diaphragm 340 may be moved toward and into the 
first section and thus positioned closer to the cap 330. The 
surface 342 extends in the housing 310 substantially parallel 
to the cap 330 in the second and third positions. 
be bordered by a cap 330. The cap 330 may extend over a 25 
portion or the entire upper surface 321. In some embodi-
ments, the cap 330 may be a rigid cap. In further embodi-
ments, the cap 33 0 may be fixedly attached to the housing 310 
The second section 350 of the fluid pump may include a 
mechanical actuator 360 configured to drive the diaphragm 
340. In some embodiments, the mechanical actuator 360 may 
include a piston 362. In some embodiments, the piston 362 
may be fixedly attached to the diaphragm 340 by a fastener. by a fastener 332. In some embodiments, the fastener 332 
may be a locking ring. In other embodiments, the fastener 
may be any known fastener. 
In some embodiments, the cap 330 may include at least one 
connector or adapter for tubing. In some embodiments, the 
connector or adapter may be a port. In further embodiments, 
the cap 330 may include a connectoror adaptor for each of the 
fluid conduits of the fluid chamber. In some embodiments, the 
cap 330 may include a first connector 334 and a second 
connector 336. In some embodiments, the connectors 334, 
336 may be any known female luer lock posts. 
30 The fastener 366 is a cynoacrylate. In some embodiments, the 
fastener 366 may include a rolling bearing connected to a 
connecting pin of the rod. In further embodiments, the pump 
may include a rod 364. In some embodiments, the piston 362 
may be connected to the rod 364 by a fastener, an adapter or 
35 connector 366. In some embodiments, the fastener 366 may 
include a connecting pin 365 and a roller bearing 367 (shown 
in FIG. 4). 
All or some of the components of the pump housing may be 
sterilized and intended for single use. 
According to some embodiments, the first and second sec-
tions and the cap may be made of materials such asAccura 60. 
Fluid Pump Motor & Motor Housing 
According to embodiments, the pump 300 may be actuated 
by a motor. The pump housing 310 may be removably 
The connectors may be positioned on the cap 330 as mirror 40 
images of each other. Each of the connectors may be in fluid 
connection with the respective fluid conduits of the fluid 
chamber 322. The connectors may overlap the respective 
fluid conduit so that the tubing is in fluid connection with the 
respective fluid conduit and may be configured to allow fluid 45 attached to a motor by an adapter or connector. In some 
embodiments, the connector may be a rolling bearing. In 
some embodiments, the connector may be disposed at the end 
of the rod 364. For example, the rod may include a connector 
368 shown in FIG. 3. The connector may be a roller bearing. 
to flow through the fluid chamber 322. 
In some embodiments, the first section 320 may further 
include a cavity 324. The cavity 324 may be configured to 
fixedly hold an incompressible fluid or material. In some 
embodiments, the cavity 324 may be filled with saline. The 
cavity 324 may be below the chamber 322 and border the 
lower surface 323. 
50 In other embodiments, the connector may be placed on the 
piston. 
As shown in FIG. 3, the first section320mayhave a surface 
3 26 that extends outwardly from the housing 310. The surface 
326 may shaped like a flange. The second section 350 may 
have a surface 356 that extends outwardly from the housing 
310. The surface 356 may also be shaped like a flange. The 
surfaces 326 and 356 may be of corresponding shape and size. 
In some embodiments, the motor mounts and connectors, 
such as roller bearings, may be made of stainless steel. The 
connecting pins, rods and pistons may be made of materials, 
55 such as Somos® NeXt. 
In some embodiments, the fluid pump housing 310 may 
further include a diaphragm 340. In some embodiments, the 60 
diaphragm 340 may be disposed between the first section 320 
and the second section 350. In some embodiments, the dia-
phragm 340 may be fixedly attached to the housing between 
the first and second sections of the pump. The diaphragm 340 
may be made of an elastomeric or flexible material, such as 65 
neoprene. Preferably, the diaphragm 340 is made of a material 
that is able to sustain a prolonged lifetime when repeatedly 
In some embodiments, the fluid management systems may 
further include a motor. In some embodiments, the systems 
may include a motor for each pump included in the fluid 
management systems. In other embodiments, the systems 
may include a motor for two or more pumps. 
In some embodiments, the pump may be actuated by a 
motor to move the fluid along the fluid path or loop. To move 
the fluid along, the fluid chamber may be deflected by trans-
ferring a force through the cavity that contains the incom-
pressible solution from the diaphragm on the bottom that is 
driven by a piston. The motor may drive the mechanical 
actuator (piston and rod system). The driving of the actuator 
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of the motor may also trigger the corresponding set of pinch 
valves allowing control of fluid direction. 
The piston subsystem may be similar to that of a recipro-
cating piston in a combustion engine. A flywheel mounted to 
the motor may rotate providing periodic movement to a rod 5 
through a driving post and then on to a piston. The piston 
attached to a rolling diaphragm may transfer the force to an 
incompressible fluid (saline) which will then cause the 
deflection of the fluid chamber. The direction change from 
rotational to linear may be accommodated via a jointed cou- 10 
piing at the base of the piston attached to the rod. All motion 
may thereby be transferred to the membrane system. 
In some embodiments, the motion of the mechanical actua-
tor (the rod and piston system) may be a controlled by a 
controller and a motor. The motor may be a motor capable of 15 
being controlled by a main controller or a combination of 
controller system (such as an EtherNet/IP Drive) and motor. 
In some embodiments, the pump may be disposed between 
a set of valves. The movement of the fluid chamber may be 
collectively controlled with respect with the valves and the 20 
motor. In particular, the deflection of the fluid chamber may 
provide a suction and expulsion of the fluid into and out of the 
fluid chamber, respectively, when synchronously paired to a 
set of pinch valves. When the valve prior to the pump is open 
and the valve after the pump is closed, the piston may be on 25 
the downstroke providing suction to pull the fluid into the 
chamber. Once the flywheel reaches bottom dead center (the 
piston moved as far away from the pump 3 00 ), the valves state 
changes and the piston causes the fluid to be expelled from the 
chamber. When the valve prior to the pump is closed and the 30 
valve after the pump is open, the piston may be on the 
upstroke providing force to move the fluid out of the chamber. 
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circuits or loops. The number of fluid circuits or loops of the 
devices and systems may be modified according to the fluid 
needs and functions needed for treatment of the patient. For 
example, the patient may not require the therapies provided 
by all of the fluid circuits or loops. 
In some embodiments, the devices and systems may be 
configured or designed to have any combination of the fol-
lowing fluid circuits or loops: a blood loop, a replacement 
fluid loop (CVVH mode), a dialysate loop (CVVDH mode), 
and an offset loop. FIG. 2 shows an example of a system 200 
that includes a blood loop 220, a replacement fluid loop 240, 
a dialysate loop 270, and an offset loop 280. 
The blood loop 220 may be a closed-loop pathofblood 210 
that is circulated out of a patient 202, filtered, replenished, 
and returned to the patient. The replacement fluid loop 240 
may be the closed-loop path where the waste products from 
the blood are extracted and replaced with the substantially the 
same amount of a prescribed replacement fluid during the 
CVVH mode. The dialysate loop 270 may be the closed-loop 
path where dialysate is added to the hemofilter for extraction 
of the waste products from the blood during the CVVDH 
mode. The offset loop 280 may be the closed-loop path that is 
configured to allow an adjustment of the volume ofreplace-
ment fluid by the clinician. 
The blood loop 220 may include at least one fluid sensor 
222 for sensing, detecting or measuring the flow characteris-
tics or pressure, or combination thereof, of the blood 210 
leaving the patient. In further embodiments, the blood loop 
220 includes at least a first valve 224, a second valve 228, and 
a fluid pump 226. The first valve 224, the second valve 228, 
and the blood pump 226 may be collectively controlled (by a 
controller) to move the blood 210 through the fluid pump 226 
like the embodiments described above. 
In some embodiments, the fluid pump 226 may be config-
The configuration of the valves and pump allow for the 
reduction of fluid volume by not having to pass an internal 
compartment in an internal or pass-through type valve. 
FIG. 4 shows the pump 300 according to embodiments 
disposed within the system connected to a motor 400. As 
shown in FIG. 4, the motor 400 may further include a plurality 
35 ured to manage small volumes of blood. In some embodi-
ments, the fluid pump 226 may correspond to the fluid pump 
300 shown in FIG. 3 (described above). In other embodi-
ments, the fluid pump 226 may correspond to other known 
of motor mounts 410. Although two motor mounts are shown 
in the figure, the system may include any number of mounts. 40 
The motor 400 may include a cam shaft 412 that is connected 
to the rod 364. The rod 364 may be connected via connector 
368. The connector may be a roller bearing. The cam shaft 
may have a corresponding shape to the connector. The motor 
may have an encoder to allow for a closed loop feedback 45 
control system. 
In some embodiments, the fluid management systems may 
further include a pump receiving member 420 for each pump 
of the system. According to some embodiments, the pump 
receiving member may be made of materials such as 50 
ACCURA® 60. Each pump receiving member may be struc-
tured and configured so that the pump has no remaining 
degrees of freedom to allow for arigid system. The pump 300 
may be disposed within the receiver. The pump receiving 
member may also be structured and configured to prohibit 55 
rotational motion. The receiver 420 may have a recess 422 
that corresponds to the shapes of the extending surfaces of the 
first and second sections of the pump 300 (e.g., the flanges of 
the pump 300) so that the rotational motion is prohibited. The 
pump 300 may further be secured into position by fasteners, 60 
such as screws. 
Fluid Circuits or Loops 
According to some embodiments, the components of the 
devices and systems may be configured or designed to have a 
plurality of fluid treatment therapies. The fluid treatment 65 
therapies may be performed by fluid circuits or loops (paths). 
The devices and systems may include any number of fluid 
fluid pumps. 
The blood loop 220 may further include a hemofilter 232. 
The hemofilter 232 may be a semi-permeable membrane that 
provides a system by which toxins from the blood can be 
removed via a method of convective drag or dialytic clear-
ance. The hemofilter 232 may include a plurality of ports. In 
some embodiments, the hemofilter 232 may include at least a 
blood input, a blood output port, a port for ultrafiltrate/dialy-
sate output. In further embodiments, the hemofilter 232 may 
further include a dialysate input. The hemofilter 232 may be 
any known commercially available hemofilter. The blood 
loop may further include a sensor 230 before the hemofilter 
232 and a sensor 234 after the hemofilter. 
Afterthe blood 110 exits the fluid pump 226 via valve 228, 
the blood flows through or by the sensor 230 before flowing 
through the hemofilter 232. The sensor 232 may be config-
ured to detect or measure the fluid characteristics of the blood 
entering the hemofilter. The blood exiting the hemofilter may 
then flow through or by sensor 234 that measures the fluid 
characteristics of the blood exiting the hemofilter. The enter-
ing and exiting measurements may be compared by the sys-
tem to determine the operation status of the hemofilter. If a 
malfunction or deterioration of the operation of the hemofilter 
is determined, the system may trigger an alarm (described 
further below). 
In the CVVH therapy mode, as blood is pumped through 
the hemofilter, the toxins removed from the blood (as a result 
of the radial pressure) result in the creation of an ultrafiltrate 
through the pores in the membrane. The ultrafiltrate may then 
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exit the hemofilter via the ultrafiltrate/dialysate output and 
flow to the ultrafiltrate collection reservoir or bag 250. In the 
CVVHD therapy mode, as blood is pumped through the 
hemofilter, dialysate enters the hemofilter via the dialysate 
input and is pumped through the hemofilter in the opposite 5 
direction of the blood flow on the opposite side of the mem-
brane of the hemofilter. The pressures and dialysate remove 
the toxins from the blood and the toxins are thereby added to 
the dialysate through the pores in the membrane. The dialy-
sate may then exit the hemofilter via the ultrafiltrate/dialysate 10 
output and flow through the dialysate fluid loop 170. 
The systems may further include an air detector 236 and a 
third (emergency) valve 238. The air detector 236 and emer-
gency valve 238 may be disposed in the blood loop directly 
before the blood returns to the patient. The air detector 236 15 
may be any known air detector. The air detector 236 may use 
ultrasonic waves to determine whether there are any poten-
tially hazardous air bubbles in the tubing before the blood 
returns to the patient. The tubing may be simply placed in the 
air detector and does not require any direct interaction with 20 
the blood. Upon sensing any significant amounts of air in the 
blood loop, the system may trigger and alarm and immedi-
ately prohibit any further flow by activating the emergency 
valve 238 until the loop has been purged of air. During the 
prime sequence, the air detector may also be disabled to allow 25 
for fluid to propagate the system. The prime sequence may be 
conducted without having a patient coupled to the system. 
During the CVVH therapy mode, according to some 
embodiments, the systems may operate a replacement fluid 
loop 240. The ultrafiltrate 212 exiting the hemofilter 232 may 30 
enter the replacement fluid loop 240 toward the ultrafiltrate 
reservoir 250. The replacement fluid loop 240 may include a 
blood detector 242. The blood detector 242 may be any 
known blood detector. The blood detector 242 may be placed 
in the replacement fluid loop 240 after the hemofilter 23 2. The 35 
tubing may be run through the detector 242 without interact-
ing with the ultrafiltrate. The blood detector 242 may be 
configured to detect the operation status of the hemofilter 232. 
For example the blood detector 242 may be configured to 
detect color changes in the ultrafiltrate exiting the hemofilter 40 
232. Based on the detection, the system may be configured to 
trigger an alarm alerting personnel that there may be a hemo-
filter operation error, such as rupture in the hemofilter that 
would indicate a need to change hemofilters. 
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The pump 266 may be between (sixth) valve 262 and (sev-
enth) valve 264. The pump 266 may be configured to pump 
the same or the substantially the same volume of replacement 
fluid 213 from the replacement fluid reservoir 260 as the 
volume of ultrafiltrate 212 collected in the ultrafiltrate collec-
tion reservoir 250. Each set of valves and the pump may be 
collectively controlled (by a controller) to move the blood 
through the respective fluid pump like the embodiments 
described above. 
In some embodiments, the fluid balance system may 
include two motors that each controls one of the two pumps. 
In other embodiments, the fluid balance system may include 
one motor that separately controls the two pumps. In these 
embodiments, a controller may individually control the col-
lective configuration of set of valves and pump for the 
replacement fluid and the collection configuration of set of 
valves and pump for the ultrafiltrate. In some embodiments, 
the fluid balance system may include the same or different 
pumps. 
In some embodiments, both or one of the pump housings of 
the fluid balance system may correspond to the pump housing 
shown in FIG. 3. FIG. 5 shows an example of a system 500 
having a fluid balance system 510 that includes two pump 
housings like the housing shown in FIG. 3. As shown in FIG. 
5, the fluid balance system 510 may include two pumps 512 
and 514. These pumps 512 and 514 may be respectively 
connected to pistons 532 and 534. The pistons of these pumps 
may be linearly offset. For example, one of the pistons 532 
and 534 may have a starting position in the uptake position 
and the other one of the pistons 532 and 534 may have a 
starting position in the opposite position, the downtake posi-
tion. 
FIG. 5 shows the two pumps 512 and 514 connected to a 
single shaft 530 connected to a single motor 550. The motor 
may be capable if and configured to drive the two pumps 
simultaneously, thereby a single drive system powers two 
mechanically coupled pumps. 
According to some embodiments, the shaft 530 may 
include a first gear that interfaces and meshes with a second 
gear. The second gear may be configured to serve two pur-
poses-the first is to transfer the rotational motion of the 
motor to the pump system described in the blood loop, the 
second is to concurrently transfer rotational motion to a shaft 
by which another flywheel is connected on the opposing end. 
The shaft may be supported via two roller bearing stands 
mounted to the enclosure. By having the second gear and 
flywheel mounted in such a fashion on a common shaft 
whereby the driving posts are 180° out of phase respective to 
50 each other, a perfect or near perfect fluid balance may be 
achieved. When the flywheel controlling the ultrafiltrate is on 
an upstroke, the flywheel controlling the replacement fluid 
will be in the exact same position on a downstroke. 
The replacement fluid loop 240 may include a fluid balance 45 
system. The fluid balance system may be configured so that 
the volume of replacement fluid is added from the replace-
ment fluid reservoir 260 is the same as or substantially the 
same volume of ultrafiltrate removed from the blood. In some 
embodiments, the fluid balance system may include two fluid 
pumps that are individually controlled to be offset of each 
other. The pumps may be controlled so that the motions are 
directly opposite of each other. By setting the two pistons 
motion directly opposite of each other, (substantially or near) 
perfect fluid balance may be achieved. The first pump may 
receive the ultrafiltrate that exited the hemofilter and the 
second pump may receive the replacement fluid that will 
replace the ultrafiltrate removed from the blood. As shown in 
FIG. 2, the replacement fluid loop 240 may include pump 246 
for pumping the ultrafiltrate to the ultrafiltrate (collection) 
reservoir 250 and pump 266 for pumping the replacement 
fluid from a replacement fluid reservoir 260. 
The system may further include a set of valves for each of 
the pumps. As shown in FIG. 2, the pump 246 may be between 
(fourth) valve 244 and a (fifth) valve 248. The pump 246 may 
be configured to pump the ultrafiltrate 212 removed via the 
hemofilter 232 to the ultrafiltrate collection reservoir 250. 
These embodiments also address the common issue asso-
55 ciated with the production ofultrafiltrate through a hemofil-
ter-the rate of production ofultrafiltrate. Due to the nature 
and efficiency of hemofilters, the initial ultrafiltrate produc-
tion rate at the beginning of a cycle may be quite brisk and be 
higher than desired. To counteract this phenomenon, the 
60 coupled pump system according to may provide fluid balance 
by allowing the system to run as intended. In other embodi-
ments, the valves may be actuated to further counteract this 
phenomenon. The valves may be actuated via the control 
system to reduce the flow to a prescribed amount. The back-
65 pressure of the system will prevent the flow from continuing 
down the path. Positive pressure will not be created by nature 
of obstructed tubing path providing a controlled closed sys-
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tern. By using the same pump system as the blood pump, costs 
may also be reduced and uniformity among subsystems may 
be allowed. 
In other embodiments, two pumps 612 and 614 may be 
attached to pistons in a V-type configuration of the pump 
systems with a single motor providing the driving force 
through a crankshaft to two pistons as shown in FIG. 6. The 
pump housing may be same as or similar to the pump housing 
shown in FIG. 3. 
In other embodiments, the fluid balance system may be any 
known fluid balance system, such as the system described in 
U.S. application Ser. No. 12/663,253, which is incorporated 
in its entirety. 
In some embodiments, the replacement fluid loop 240 may 
include a fluid heater 268. The fluid theater 268 may be any 
known fluid heater. The fluid heater 268 may address the 
thermal concerns in the blood loop and replacement fluid 
loop. Because of convective heat transfer between the blood, 
tubing, and ambient air temperatures, a fluid heater may be 
placed after the hemofilter 23 2 and before the patient 202. The 
heater 268 may be configured to heat replacement fluid 213 
that will be mixed with blood 210 directly before return to the 
patient 202. The heater 268 may also be configured to main-
tain the standard core temperature with both upper and lower 
limits to prevent hypothermia or hyperthermia in the patient. 
The replacement fluid loop 240 may further include at least 
one temperature monitor detector or system 269. The tem-
perature monitoring system 269 may be combined or separate 
from the fluid heater 268. The temperature monitoring system 
may include at least one of known temperature sensor. The 
temperature monitoring system may be disposed at one or a 
plurality of locations along the replacement fluid loop to 
provide a closed loop feedback system to allow for the device 
to adjust fluid temperature and process temperature data in 
real time. The heater may be isolated from the loop for the 
benefit of sterility. The replacement fluid 213 may be heated 
convectively when passing through a heated area while still 
contained in its tubing. 
During the CVVHD therapy mode, according to some 
embodiments, the systems may operate a dialysate fluid loop 
270. During this mode, the dialysate or replacement fluid 213 
may be pumped from the replacement fluid or dialysate res-
ervoir 260 via the pump 266 and valves 262 and 264 configu-
ration. Although the figures show that the dialysate 214 is 
pumped from the same reservoir from which the replacement 
fluid is pumped for the fluid balance loop, the system, in other 
embodiments, may include a separate reservoir for the dialy-
sate. The controller controls the flow rate and volume of the 
dialysate removed from the reservoir via the pump configu-
ration. The dialysate 214 is then pumped to the hemofilter 
232. The dialysate 214 enters the hemofilter via a dialysate 
port. The hemofilter 232 then removes the toxins and disposes 
of the discarded dialysate 215. In some embodiments, the 
hemofilter disposes of the discarded dialysate through the 
same flow path as discarded ultrafiltrate. For example, the 
discarded dialysate 215 flows through the blood detector 242, 
the pump 246 via the operation of valves 244 and 248, to the 
ultrafiltrate/dialysate reservoir 250 for collection. 
According to some embodiments, the systems may also 
include an offset loop 280. The offset loop may provide 
adjustability for any deviations from the replacement fluid 
loop. For example, in certain conditions, clinicians may need 
to impose a positive or negative state of fluid balance. The 
offset loop will provide this functionality. 
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valve 286 and pump 284. The pump 284 may be the same as 
or similar to pump shown in the figures. The pump 284 and 
valves may be collectively controlled to control the volume of 
replacement fluid via the replacement fluid reservoir 260 to be 
added or removed from the replacement fluid 213 to be pro-
vided to the patient 202. 
Configuration of Devices and Systems 
In some embodiments, the system may be housed in a 
modular or portable unit. The modular unit may have housing 
10 
configured to control sterility of the system. For example the 
components of the system may be disposed at different self-
contained sections of the housing. The self-contained sec-
tions may improve sterility of the system. The sections may 
15 be separated by an overlay or surface. The surface may be 
made of a plastic or acrylic material. 
In some embodiments, the housing may include a plurality 
of sections. In some embodiments, the mechanical compo-
nents and electronics of the system may be self contained and 
20 separated from the (single-use or replaceable) items con-
nected to the system via connectors and/or adapters. For 
example, the processing components such as controllers may 
be provided underneath the mechanical components (such as 
the motor) in a self-contained section. The mechanical com-
25 ponents may be further separated from the single-use items 
(such as the pump and tubing) in a self-contained section. 
These items may include but are not limited to the pump 
housing that may be connected to the motor within the hous-
ing as well as tubing that connects to the replacement fluid 
30 reservoirs and ultrafiltrate (collection) reservoirs. According 
to some embodiments, the replacement fluid reservoirs and 
ultrafiltrate (collection) reservoirs may be external to the sys-
tem housing and connected to the system via medical tubing. 
FIG. 5 shows an example of the modular housing (with the 
35 tubing not shown). 
In some embodiments, the housing may include adapters or 
connectors configured for the connectable system compo-
nents. The connectors may be configured to removably attach 
the connectable system components to the housing or system 
40 so that the connectable system components can be connected 
to the system during operation and may then later be removed 
and replaced with new components. In some embodiments, 
the components of the system may include connectors or 
adapters configured to receive the connectable system com-
45 ponents. For example, pinch valves 580 may each include a 
connector for the tubing extending from the pumps. The 
hemofilter 570 may also include a connector or receiver 572 
to receive a hemofilter. 
In some embodiments, the system 500 may include at least 
50 one pump receiving member 520. The pump receiving mem-
bers 520 may be configured to have a depression in a surface 
to receive each pump. FIG. 5 shows four pump receiving 
members, one pump receiving member for each pump. The 
pump receiving members 520 may be configured to receive 
55 any pump of the system, for example, pumps 512, 514, 516, 
and 518. The pumps may be for the replacement fluid loop, as 
well as the pumps forthe other loops of the system. The pump 
receiving member 520 may be made of an acrylic material 
that is capable of being sterilized. Although only a portion is 
60 shown, it would be understood that each pump receiving 
member 520 may be a part of a housing divider configured to 
separate and self-contain the mechanical components, such 
as motors 550 and 552 from the connectable system compo-
nents. 
In some embodiments, the offset loop 280 may include 65 
valves and pump configuration similar to the blood loop. The 
offset loop 280 may include a (eighth) valve 282 and a (ninth) 
It will be further understood that the processing compo-
nents, such as controller 560 may be further separated from 
the mechanical components by a self-containing layer 562. 
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According to some embodiments, a motor may drive to at 
least one pump. As shown in FIG. 5, the motor 550 may be 
connected to and drive the fluid balance system including 
pumps 512 and 514. The other pumps, 516 and 518, config-
ured for the blood and offset loops, may each be connected to 
and be configured to be driven by motors 552 and 554, respec-
tively. 
Connectable/Disposable System Components: 
16 
devices may include but are not limited to an ECMO device, 
cardiopulmonary bypass device, ventricular assist device, 
plasma exchange device, apheresis device, or hemoperfusion 
device. According to further embodiments, the inputs may 
further include patient type, such as pediatric or adult. 
The inputs may further include operating parameters. In 
some embodiments, the operating parameters may be specific 
to the mode, adjunct therapy, other connected devices, patient 
type, or any combination thereof. In some embodiments, any According to some embodiments, the system may be con-
figured to receive single use or disposable connectable items. 
In some embodiments, these items may be sterilized. 
According to some embodiments, the items may include 
but are not limited to the pump housing, tubing, and hemo-
filter. According to some embodiments, a portion or combi-
nation of the single use items may be sold as kit. 
10 or all of the operating parameters may be stored for each 
mode, adjunct therapy, other connected devices, patient type, 
or any combination thereof. In further embodiments, the con-
troller may automatically control all or any of the operating 
parameters forthe system based on the mode, adjunct therapy, 
In some embodiments, the kit may include at least one 
pump housing that includes all or portions of the pump hous-
ing shown in FIG. 3. The pump housing will at least include 
15 other connected devices, patient type, or any combination 
thereof selected. In other embodiments, the user may input all 
or any of the operating parameters for the mode, adjunct 
therapy, other connected devices, patient type, or any combi-
nation thereof selected. a connector, such as roller bearing, configured to connect to a 
motor of the system. In further embodiments, the kit may 20 
include a plurality of pump housings. For example, in some 
embodiments, the kit may include one, two, three or four 
pump housings. In alternative embodiments, the kit may 
include additional pump housings. 
In further embodiments, the kit may include tubing for the 25 
system. The tubing may be in addition to or in alternative to 
the pump housing. In some embodiments, the kit may further 
According to some embodiments, the operating param-
eters may be inputted or entered into the user interface using 
an input device such as a keyboard or a touch screen. In some 
embodiments, the operating parameters may be entered on 
the main screen shown in FIG. 8, which may be accessed via 
button 810. In some embodiments, the inputted operating 
parameters may be adjusted during operation, for example, 
by selecting the reset button. 
According to some embodiments, the operating param-
eters may be entered by selecting an operating parameter 
or alternatively include a tube frame. The tube frame includ-
ing sections for disposing all or most of the tubing. The tubing 
may be configured as a part of the tube frame. 
In further embodiments, the kit may include at least one 
connector configured to connect the tubing and/or pump to 
the system. 
30 shown on the screen. In some embodiments, the operating 
parameters may include volumetric flow rates 820 for several 
parameters. The flow rates may be set for any one or combi-
nation of operating parameters. The operating parameters 
In further embodiments, the kit may include a hemofilter. 
The hemofilter may be in addition to or in alternative to the 35 
pump housing and tubing. 
Control Module and Display 
According to some embodiments, the display system may 
further include a user interface. In some embodiments, the 
instructions for user interface may be programmed and stored 40 
in the memory of the display system. In other embodiments, 
the instructions for the user interface may be programmed and 
stored in the memory of the fluid therapy system. In further 
embodiments, the instructions for the user interface may be 
programmed and stored remotely and accessed by either or 45 
both the display system and the fluid therapy system. 
According some embodiments, the user interface may be 
programmed to control or provide instructions to control the 
systems and devices of the disclosure. The user interface may 
control or provide instructions to control the systems and 50 
devices of the disclosure based on inputs entered by the user 
into the user interface using an input device. According to 
embodiments, the controller(s) may control the system 
according to the inputs. 
According to the some embodiments, the inputs may 55 
include treatment mode. Treatment modes may include but 
are not limited to CRRT, CVVH, CVVHD, and CVVHDF 
modes. One or a combination of the treatment modes may be 
selected. In other embodiments, the inputs may further 
include another or adjunct medical fluid treatment therapy or 60 
extracorporeal treatment systems and devices (also referred 
to as other medical fluid treatment therapy systems and 
devices) for which the system will be used in conjunction. In 
some embodiments, the system may be connected to the other 
medical fluid treatment therapy systems and devices. In fur- 65 
ther embodiments, the controller may control the other medi-
cal fluid treatment therapy systems and devices. These other 
may, include, but are not limited to, blood 822, ultrafiltrate 
(UF) 824, replacement fluid (RF) 826, offset (UF-RF) 828, 
and dialysate 830. In some embodiments, the volumetric flow 
rates may be inputted in mL/min. In further embodiments, the 
ranges for inputted flow rates may be predetermined. Thee 
ranges may be based on the patient type, such as an adult or a 
pediatric. For example, the blood volumetric flow rate may be 
limited to the range ofO to 150. The UF, dialysate, and offset 
volumetric flow rates may also be limited to a predetermined 
range. In further embodiments, users may be able to input a 
flow time in hours or minutes in time left field 840. The 
remaining flow time may also be displayed in that or a differ-
ent field. The countdown may be helpful indicator when the 
materials, such as the replacement fluid or dialysate, may be 
getting low. 
The user may start delivering therapy via the systems 
according to the embodiments by selecting the power button. 
Once the system is power, the graphical representation 850 of 
the operation status of the system may be visible on the 
display screen. The operating status may include but are not 
limited to the status of the pumps in motion, valves opening 
and closing, fluid volumes, status of blood and air detectors, 
patient exit pressure, filter enter pressure, patient enter pres-
sure, heater temperature, and time remaining For example, 
the screen shown in FIG. 15 shows an input screen for adjust-
ing the heater temperature. While the device is running, flow 
rates may be adjusted and counters may be reset. 
The user interface may include certain operation protocols 
when certain conditions, such as air or blood are detected. For 
example, operation protocols may include automatically 
shutting down the machine and setting an alarm condition. 
The alarm condition may be programmed so that the condi-
tion must be cleared before the system will restart. The oper-
ating protocols may be manually bypass or modified based on 
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the needs of the user. In some embodiments, the operation 
protocols may not be adjusted unless the user has higher level 
access, such as administrator access to the user interface. 
The user interface may further include at least one acces-
sory screen. The screens may include but are not limited to 
graphing, alarms, prime, lock, heater, stroke, and manual. 
These screens may be accessible by fields or icons on 860 the 
top of each screen. 
According to some embodiments, the controller may con-
trol the system based on the operating parameters. The con- 10 
trailer may also control the system based on the operation 
status of the system. FIG. 7 shows the schematic 700 of the 
control parameters for a controller 710. In some embodi-
ments, the controller may control the system by transmitted 
outputs 730 to the system. In further embodiments, the con- 15 
trailer may control a connected or adjunct therapy device(s) 
by transmitting outputs 730 to the connected or adjunct 
therapy device(s). 
In some embodiments, the outputs may be based on inputs 
720 received regarding the operating status of the system. The 20 
outputs may be based on the comparison of the received 
inputs to the prestored or inputted operating parameters. 
The inputs 720 may be based on the sensors and/or detec-
tors included in the system. The sensors and/or detectors may 
include but are not limited to fluid sensor(s) 722, detector(s) 25 
724, and temperature sensor(s) 726. In other embodiments, 
the inputs may be received from other and additional sensors 
and detectors from the system. In other embodiments, the 
inputs may be received from other systems, such as connected 
18 
the flow rate, and offset. In further embodiments, the control-
ler may control replacement fluid heater 738. The controller 
may cause the heater to increase or decrease the heat pro-
duced. In further embodiments, the controller may control the 
system according to protocols when the controller receives 
inputs of certain conditions. The protocols may include but 
are not limited to automatically shutting down the system, 
shutting down a component of the system, or activation of an 
alarm. 
According to some embodiments, the controller may also 
transmit the information received from the inputs and/or the 
record of the outputs to connected or adjunct therapy devices. 
According to some embodiments, the accessory screens 
may include a graphing screen, like the screen 900 shown in 
FIG. 9. The graphing screen may allow the user to view the 
operating parameters of the system based on date/time group 
process variables. These variables may include but are not 
limited to volumetric flow rates, motor speed, and blood 
pressures. The user interface may be programmed to process 
these variables to a SQL server database that could then be 
queried by any medical record system. Parameters of interest 
could either be sampled at some pre determined interval, such 
as an hourly or daily interval, or be event driven like a process 
variable exceeding the alarm limit. 
The display system may be connected to the local area 
network via Ethernet making remote viewing possible. This 
would enable others to see the process variables using the 
graphing screen without having to physically be in the 
or adjunct therapy devices. 30 patient's room. Someone else could, from a distance, trouble 
shoot a faulty detector and recommend corrective action. The controller may receive information from the fluid sen-
sors 722. The information may include but is not limited to the 
fluid characteristics of the fluid(s) flowing through the sys-
tem, such as blood, replacement fluid, ultrafiltrate, and dialy-
sate. In some embodiments, the detectors 724 may include but 35 
are not limited to the blood detector and air detector. The 
The graphical trend shown in FIG. 9 may have any number 
of parameters for simultaneous observation. The screen 
shows eight possible parameters 910 but may be include 
additional parameters. The parameters may be programmed 
or selected to update every few seconds or zoom in and out at 
an area of interest. This will provide t the ability to perform 
real time data acquisition. Also, this screen may be valuable 
and helpful when troubleshooting the system, such as a faulty 
information may receive information from the detectors 724. 
The information may include but is not limited to the detec-
tion of air in the blood or blood in the ultrafiltrate. In some 
embodiments, the temperature sensors 726 may provide 
information regarding the fluid flowing through the system. 
40 transducer or when correlating the effect of a pump speed 
change on filter differential pressure. 
According to the inputs, the controller may transmit one or 
more outputs to the system. In other embodiments, the con-
troller may transmit one or more outputs to another system. In 
some embodiments, the outputs may be transmitted to hard- 45 
ware elements of the system. The hardware elements include 
but are not limited to memory 732, pinch valve(s) 734, display 
736, replacement fluid heater 738, pump(s) 740, and proto-
cols 742. 
The accessory screens may further include an alarm history 
screen and an alarm summary screen. The alarms may be 
activated when the controller determines based on the sensor 
or detectors that at least one component of the system is not 
operating properly. The alarm history screen, an example 
shown in FIG. 10, may provide access to all alarms that have 
ever occurred. The alarm summary screen may be configured 
to display active alarms which have not been acknowledged. 
50 When there is an active, the user may be notified. For 
example, the smiley face icon, as shown in the main screen 
800, in the Alarms button, may change into a flashing red mad 
face to indicate there is a problem. Acknowledging a critical 
alarm that has shut down the unit may allow the system to be 
According to some embodiments, the controller may trans-
mit the information received from the inputs to a memory 
device for storage. In further embodiments, the information 
received from the inputs may be transmitted to a network 
computer for storage. The controller may also transmit a 
record of any or all of the transmitted outputs, such as the 
control instructions), to a memory or network computer for 
storage. The controller may also transmit the information 
received from the inputs to a display device for display. In 
further embodiments, the controller may transmit record of 
any or all of the transmitted outputs to a display device for 60 
display. 
55 restarted; however, unless the fault is corrected it will just shut 
down again. Faults may be predefined or defined according to 
the lower and upper limits of the process variables being 
exceeded. 
The controller may also control the system based on the 
inputs. In some embodiments, the controller may control any 
one or combination of the pinch valve and pump systems 
based on the inputs. The controller may control the operation 65 
status of the pinch valve and pump system. The operation 
status may include but is not limited to timing, dwell angle, 
The accessory screens may further include a manual 
screen, as shown in FIG. 11. The manual screen may allow 
access for manual operation and configuration of the system. 
This screen may be password or credential protected for a 
higher administrator, repair, maintenance, or biomedical 
engineering use. From this screen, the user may manually 
override the operation of the system. For example, a user may 
manually disable the air and blood detector, bypass the pres-
sure transmitters, and change the dwell angle on the valve 
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opening and closing for example. The user may be able to 
enter set points for pump volumes and alarm pressures. 
The accessory screens may further include a valve dwell 
screen as shown in FIG. 12. The valve dwell screen may 
display the dwell angle of each valve in operation in the 
system. 
20 
5. The fluid pump according to claim 4, wherein: 
the diaphragm is configured to transfer force to the incom-
pressible fluid when the diaphragm is in the second 
position, and the incompressible fluid is configured to 
move the fluid through the fluid chamber. 
6. The fluid pump according to claim 4, wherein the second 
section includes a piston. The accessory screens may further include a locked screen 
7. The fluid pump according to claim 6, wherein the first 
section has an extending surface and the second section has an 
10 extending surface, the extending surface of the first section 
facing the extending surface of the second section. 
as shown in FIG. 13. This screen may display information but 
will not allow changes to the current therapy to unauthorized 
users. The screen may be by protected by a password or 
specific credentials. The credentials may include but are not 
limited to an access badge, smart card, biometric device, bar 
code. In order to make changes to therapy (by unlocking the 
screen and providing access to the main screen, for example), 15 
the user may have to enter or provide a correct password or 
proper credentials. 
An example of main screen for when the system is operat-
ing properly is shown in FIG. 14. An example of when there 
is an error, for example, with the dialysate is shown in FIG. 20 
16. 
While various embodiments of the disclosure have been 
described, the description is intended to be exemplary rather 
than limiting and it will be appeared to those of ordinary skill 
in the art that may more embodiments and implementations 25 
are possible that are within the scope of the disclosure. 
What is claimed: 
1. A fluid pump for medical fluid treatment therapies con-
figured for small volumes of a fluid, comprising: 30 
a first conduit configured for inflow of the fluid; 
a second conduit configured for outflow of the fluid; 
a fluid chamber configured to move the fluid through the 
pump; 
a diaphragm configured to force the fluid through the fluid 35 
chamber by indirectly exerting force on the fluid cham-
ber; 
a connector configured to removably attach the pump to a 
motor; and 
an actuator directly connected to the diaphragm, the actua- 40 
tor being configured to move a surface of the diaphragm, 
wherein the fluid chamber includes a first surface and an 
opposing second surface, the first surface and the second 
surface defining a membrane configured to hold the fluid 
therebetween, at least one of the first and second sur- 45 
faces includes a flexible material. 
2. The fluid pump according to claim 1, wherein: 
8. The fluid pump according to claim 1, further comprising: 
a cap, the cap including ports configured to connect tubing 
to the first and second conduits. 
9. A medical fluid therapy system, comprising: 
at least one medical fluid pump, the pump including: 
a fluid chamber configured to move a fluid through the 
pump; 
a diaphragm configured to force the fluid through the 
fluid chamber by indirectly exerting force on the fluid 
chamber; 
a plurality of valves, the valves including at least a first 
valve and a second valve configured to control the 
flow of fluid through the fluid pump; 
a motor; 
a controller configured to collectively control the move-
ment of the motor and valves with respect to each other; 
and 
an actuator directly connected to the diaphragm, the actua-
tor being configured to move a surface of the diaphragm, 
wherein the fluid chamber includes a first surface and an 
opposing second surface, the first surface and the second 
surface defining a membrane configured to hold the fluid 
therebetween, at least one of the first and second sur-
faces includes a flexible material. 
10. The system according to claim 9, further comprising: 
a fluid balance system, 
the fluid balance system including a first pump and a sec-
ond pump, each pump including the fluid chamber, the 
diaphragm and the first valve and the second valve, 
wherein the first pump and second pump are offset of each 
other. 
11. The system according to claim 9, further comprising: 
a display, the display includes a user interface configured to 
enter operating parameters to control the system. 
12. The system according to claim 11, wherein the user 
interface displays the operating status of the system. 
the actuator is configured to linearly move the surface of 
the diaphragm; and 
each of the first and second surfaces includes the flexible 
material. 
13. The system according to claim 12, wherein the operat-
ing status includes flow rates of the fluid flowing through the 
50 pump and an angle of the valve. 
3. The fluid pump according to claim 1, further comprising: 
a housing, the housing including at least a first section and 
a second section; and 
wherein the first section includes a cavity filled with an 55 
incompressible fluid, the first conduit, the second con-
duit and the fluid chamber, and the cavity is disposed 
between the fluid chamber and the diaphragm. 
4. The fluid pump according to claim 3, wherein: 
the diaphragm is fixedly attached to the housing between 60 
the first section and the second section; and 
the actuator is configured to move the diaphragm between 
a first position and a second position; the first position 
corresponding to when a surface of the diaphragm pro-
trudes into the first section and the second position cor- 65 
responding to when the surface of the diaphragm pro-
trudes into the second section. 
14. The system according to claim 9, further comprising: 
at least one pump receiving member, the at least one pump 
receiving member having a depression configured to 
receive a portion of the pump, 
wherein the pump includes a housing, the housing includ-
ing at least a first section and a second section, 
wherein the first section has an extending surface and the 
second section has an extending surface, the extending 
surface of the first section facing the extending surface 
of the second section, and 
wherein the depression is configured to receive the extend-
ing surface of at least the second section. 
15. The system according to claim 14, further comprising: 
at least first and second self-contained sections, wherein 
the first self-contained section includes the controller; 
and the second self-contained section includes the pump 
receiving member. 
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16. The system according to claim 9, wherein the system is 
configured for a plurality of fluid treatment modes. 
17. The system according to claim 9, wherein the controller 
is configured to control the motor and valves based on entered 
volume parameters. 
18. The system according to claim 17, wherein an operat-
ing status of the system is stored at predetermined intervals. 
19. A disposable kit for a medical therapy system, com-
prising: 
a first conduit configured for inflow of a fluid; 10 
a second conduit configured for outflow of the fluid; 
a fluid chamber configured to move the fluid through a 
pump; 
a diaphragm configured to force the fluid through the fluid 
chamber by indirectly exerting force on the fluid cham- 15 
ber; 
a connector configured to removably attach the pump to a 
motor; and 
an actuator directly connected to the diaphragm, the actua-
tor being configured to move a surface of the diaphragm, 20 
wherein the fluid chamber includes a first surface and an 
opposing second surface, the first surface and the second 
surface defining a membrane configured to hold the fluid 
therebetween, at least one of the first and second sur-
faces includes a flexible material. 25 
20. The kit according to claim 19, further comprising: 
tubing configured for the medical therapy system. 
* * * * * 
22 
